Deutsche Bank Remains Bullish on Nu Skin Despite Recent Sharp Move Lower, Maintains Buy Rating
Bulls in shares of Nu Skin Enterprises (NYSE: NUS) are finally getting some relief Wednesday as an optimistic note from Deutsche Bank's Bill Schmitz is turning heads. The stock closed up more than 6 percent; shares have plunged about 50 percent over the last week.
Although Schmitz reduced his price target on Nu Skin shares from $150 to $115 in the note from late Tuesday, the analyst said he is maintaining a Buy rating.
The Deutsche Bank analyst believes investors are "currently discounting a significant decline in the company's Chinese business," creating an attractive entry point. He also pointed at a "pristine" balance sheet and fundamentals outside of China which "are still among best in class across the CPG universe."
With shares of Nu Skin closing Wednesday's trading session at $82.15, Schmitz's new, reduced price target implies potential upside of about 40 percent.
Latest Ratings for NUS
|Dec 2014||Bank of America||Maintains||Underperform|
|Nov 2014||Citigroup||Initiates Coverage on||Neutral|
© 2014 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.